The Effects of Enalapril and Nifedipine on Carbohydrate and Lipid Profiles in Non-Insulin-Dependent Diabetes (Niddm)

Publication Type

Journal Article

Publication Date

1994

Abstract

To compare the effects of nifedipine and enalapril on carbohydrate and lipoprotein metabolism in Chinese non-insulin-dependent diabetes mellitus (NIDDM) patients with hypertension. RESEARCH DESIGN AND METHODS--A 12-week, double-blind, randomized study of plasma lipid levels and glycemic control in patients treated with nifedipine (n = 52) or enalapril (n = 50) was conducted. None of the patients were treated with insulin. Diet and dosages of oral hypoglycemic agents remained unchanged during the 12-week treatment period. RESULTS--Mean arterial pressure was reduced more by nifedipine than by enalapril (23.1 vs. 11.1 mmHg, P < 0.001). Similar reductions in body mass index and plasma triglycerides and increases in apolipoprotein A-I were seen with both treatments, but HbA1 was reduced more during treatment with enalapril than with nifedipine (0.49 vs. 0.20%, P = 0.035) and serum apolipoprotein B (apoB) also declined more with enalapril than with nifedipine (8.2 vs. 2.3 mg/dl, P = 0.009). CONCLUSIONS--Twelve weeks of treatment with enalapril in hypertensive NIDDM patients was associated with greater improvement in glycemic control and greater reduction in serum apoB concentration, although the reduction in blood pressure was less than with nifedipine. These changes in cardiovascular risk profile warrant investigation for a longer term.

Discipline

Econometrics | Medicine and Health Sciences

Research Areas

Econometrics

Publication

Diabetes Care

Volume

17

Issue

8

First Page

859

Last Page

862

ISSN

0149-5992

Identifier

10.2337/diacare.17.8.859

Additional URL

https://doi.org/10.2337/diacare.17.8.859

This document is currently not available here.

Share

COinS